What's in Anna Posadzy-Małaczyńska's pipeline?

Anna Posadzy-Małaczyńska has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Anna Posadzy-Małaczyńska's portfolio?

Top competitors by shared drug class: Beni-Suef University, Brigham and Women's Hospital, El Shatby University Hospital for Obstetrics and Gynecology, Erasmus Medical Center, Massachusetts General Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/anna-posadzy-ma-aczy-ska.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Anna Posadzy-Małaczyńska — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anna Posadzy-Małaczyńska pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Estracomb TTS	Estracomb TTS	marketed	Hormone replacement therapy (HRT)	Estrogen receptor (ER-α, ER-β) and progesterone receptor (PR)	Endocrinology / Women's Health

Therapeutic area mix

Endocrinology / Women's Health · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Beni-Suef University · 1 shared drug class
Brigham and Women's Hospital · 1 shared drug class
El Shatby University Hospital for Obstetrics and Gynecology · 1 shared drug class
Erasmus Medical Center · 1 shared drug class
Massachusetts General Hospital · 1 shared drug class
Myovant Sciences GmbH · 1 shared drug class
Peking Union Medical College Hospital · 1 shared drug class
Scientific Research Institute of Public Health, Russian Federation · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Anna Posadzy-Małaczyńska:

Cite this brief

Drug Landscape (2026). Anna Posadzy-Małaczyńska — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/anna-posadzy-ma-aczy-ska. Accessed 2026-05-17.